Bausch Health Companies | Ativo Circulante



Current Assets Alterar Data
Amgen USD 29.03B 2.26B 2024-12
ANI Pharmaceuticals USD 527.68M 6.39M 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
Bausch Health Companies USD 5.35B 140M 2024-09
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 471.6M 4.62M 2024-12
Danaher USD 9.5B 563M 2024-12
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
Novo Nordisk 195.16B 17.66B 2024-09
Pacira USD 745.13M 55.16M 2024-12
Perrigo USD 2.48B 1.23B 2024-12
Prestige Brands USD 377.16M 3.54M 2024-12
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Zoetis USD 5.99B 296M 2024-12



Bausch Health Companies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.